Registries and Post-Marketing Data Collection

FDA Post-Marketing Surveillance
David S. Buckles, PhD, FACC
Peripheral Vascular Devices Branch
Division of Cardiovascular Devices
Office of Device Evaluation

Registries-A Dubious Panacea or the Best Thing Since Sliced Bread?
David Chen, Ph.D.
Vice President Engineering / R&D Director
Medical Metrx Solutions

The OIG: The View from the Inside . . . and What's Ahead
Dara A. Corrigan
Partner
Arnold & Porter LLP

The HIPAA Privacy Rule: Implications for CMS Proposed "Coverage With Evidence" Data Collection
Nancy L. Perkins
Partner
Arnold & Porter LLP

"Safe and Effective" Is It Enough?
Stephen Phurrough, MD, MPA
Director, Coverage and Analysis Group
Centers for Medicare and Medicaid Services

Registries: Uses and Limitations
Charles Turkelson, Ph.D.
Chief Research Analyst, Health Technology Assessment Group, ECRI
Technical Director, ECRI/AHRQ Evidence-based Practice Center

Speech: The Future of Medicare in a Growing Fiscal Storm
Jim Turner
Partner
Arnold & Porter